EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

N 6 ‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis

Song Li, Jianyuan Zhou, Shuang Wang, Qian Yang, Shulun Nie, Chunwang Ji, Xue Zhang, Shuhan Li, Xuanyu Zhou, Jiahui Chu, Xuehui Wu, Jianqiao Jiao und 12 weitere

Cancer Communications · 2025-08 · 45 (8) · 941-965

DOI: 10.1002/cac2.70034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Communications, online erschienen am 15.05.2025. Verfasst von Song Li und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P. R. China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Exosomes, Adenosine, Peritoneal Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer peritoneal metastasis is clinically challenging, given the limited treatment options and poor prognosis. The molecular mechanisms that precede gastric cancer peritoneal metastasis, known as the pre‐metastatic niche (PMN), and its relationship with N 6 ‐methyladenosine (m 6 A) modification remain unclear.

Methods

We used 87 resected gastric cancer tissues and 4 public datasets to explore the association between methyltransferase‐like 3 (METTL3) expression and gastric cancer peritoneal metastasis. Roles of m 6 A, exosomes, or macrophages in PMN formation were explored in immunocompetent mouse models through exosome treatments or macrophage modifications. Key genes and regulatory mechanisms were uncovered using mass spectrometry, RNA/miRNA sequencing, RNA‐immunoprecipitation, dual‐luciferase assays, and point mutations in the ras‐related protein Rab‐27A ( RAB27A ) in cells. Macrophage and T‐cell functions were assessed using enzyme‐linked immunosorbent assay, flow cytometry, and cytotoxicity assays.

Results

METTL3 overexpression in gastric cancer cells enhanced RAB27A translation by methylating its mRNA A502 base, facilitated by its m 6 A “reader” YTH N 6 ‐methyladenosine RNA binding protein F1 (YTHDF1), and led to increased exosome biogenesis. The miRNA‐17‐92 cluster was enriched in METTL3‐overexpressed cell‐derived exosomes and targeted SRC kinase signaling inhibitor 1 (SRCIN1) to activate SRC proto‐oncogene, non‐receptor tyrosine kinase (SRC) signaling in peritoneal macrophages. Macrophage activation skewed cytokine production towards an immunosuppressive profile in the peritoneum, elevating the levels of interleukin (IL)‐10 and tumor necrosis factor (TNF) and reducing the levels of IL‐1 and IL‐6. These cytokine shifts inhibited T cell proliferation and cytotoxic activities, which created an immunosuppressive PMN and led to peritoneal metastasis. The association between METTL3, macrophages, and peritoneal metastasis was verified in clinical samples.

Conclusions

Our study identified an intricate m 6 A‐regulated mechanism of peritoneal PMN development that is mediated by exosome‐promoted macrophages. These insights into gastric cancer peritoneal metastasis offer promising directions for translational research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsExosomesAdenosinePeritoneal NeoplasmsMethyltransferasesHumansAnimalsMicerab27 GTP-Binding ProteinsProto-Oncogene MasCell Line, TumorFemaleRNA-Binding ProteinsMaleMacrophagesGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

N6‐methyladenosineexosomesgastric cancerperitoneal metastasispre‐metastatic niche

Substanzen

AdenosineN-methyladenosineMethyltransferasesMETTL3 protein, humanMAS1 protein, humanrab27 GTP-Binding ProteinsProto-Oncogene MasRNA-Binding ProteinsYTHDF1 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P. R. China.
  • Institute of Marine Science and Technology, Shandong University, Qingdao, Shandong, P. R. China.
  • Department of Pharmacy, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P. R. China.
  • Department of Medical Oncology, Shandong Provincial Hospital of Traditional Chinese Medicine, Jinan, Shandong, P. R. China.

ORCID-Profile: Lian Liu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Li, S., Zhou, J., Wang, S., Yang, Q., Nie, S., Ji, C., Zhang, X., Li, S., Zhou, X., Chu, J., Wu, X., Jiao, J., Xu, R., Xu, Q., Huang, M., Wang, Q., Dou, L., Hu, Q., Jiang, F., …, & Liu, L. (2025). N 6 ‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis. Cancer Communications, 45(8), 941-965. https://doi.org/10.1002/cac2.70034

Vancouver

Li S, Zhou J, Wang S, Yang Q, Nie S, Ji C, et al. N 6 ‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis. Cancer Communications. 2025;45(8):941-965. doi:10.1002/cac2.70034

BibTeX
@article{Li2025,
  author = {Li, Song and Zhou, Jianyuan and Wang, Shuang and Yang, Qian and Nie, Shulun and Ji, Chunwang and Zhang, Xue and Li, Shuhan and Zhou, Xuanyu and Chu, Jiahui and Wu, Xuehui and Jiao, Jianqiao and Xu, Ruitao and Xu, Qian and Huang, Miao and Wang, Qiushi and Dou, Liliang and Hu, Qinqin and Jiang, Fan and Dai, Xin and Nan, Zhaodi and Song, Xinyu and Zhang, Di and Liu, Lian},
  title = {N 6 ‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis},
  journal = {Cancer Communications},
  year = {2025},
  volume = {45},
  number = {8},
  pages = {941--965},
  doi = {10.1002/cac2.70034}
}
Kostenlos starten →